Patents Assigned to L'Universite de Montreal
  • Patent number: 6136308
    Abstract: Symptoms of stress such as elevated blood pressure in mammals are treated, and mammalian bodies are preconditioned to manifest reduced adverse reactions to subsequently encountered stresses, by injecting into the mammalian patient a small quantity of the patient's own blood which has been previously extracted and subjected extracorporeally to at least one stressor, such as ultraviolet radiation, an oxidative environment, ozone-oxygen and mild heating, especially infra-red radiation causing mild heating. Particularly beneficial combinations of stressors are simultaneous applications of UV radiation and an ozone-oxygen gas mixture bubbled through the blood sample to provide the oxidative environment, or simultaneous application of UV radiation, ozone-oxygen gas mixtures and mild heating. One specific use of the invention is in preconditioning against ischemic-reperfusion injury, e.g. prior to surgery.
    Type: Grant
    Filed: September 11, 1998
    Date of Patent: October 24, 2000
    Assignees: Vasogen Ireland Limited, Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CHUM)
    Inventors: Johanne Tremblay, Pavel Hamet
  • Patent number: 5821354
    Abstract: The present invention relates to a radiolabeled DNA oligonucleotide, a method of preparation thereof and the therapeutic uses of this substance to prevent uncontrolled cellular proliferation. The invention also relates to devices incorporating the above radiolabeled DNA oligonucleotide for the therapeutic treatment of uncontrolled cellular proliferation. More specifically, the present invention is concerned with the prevention of restenosis by coronary delivery of radiolabeled DNA oligonucleotide at a dilatation site of an artery. This invention is also directed to a method of treatment of vascular proliferative diseases and/or other proliferative disorders such as cancer and related metastasis.
    Type: Grant
    Filed: November 26, 1996
    Date of Patent: October 13, 1998
    Assignees: Angiogene Inc., Centre de Recherche du Centre Hospitalier de l'Universite de Montreal
    Inventors: Guy Leclerc, Remi Martel